Free Newsletter
Nanotech used in search for cancer drugs
Researchers at Wake Forest University are developing a nanotech process which could potentially speed the search for new anti-cancer drugs. The "Lab-on-Bead" process involves using tiny plastic beads, each carrying a different chemical, to identify which chemicals display cancer-fighting properties. Technologies currently in use only allow researchers to screen several hundred thousand drug candidates per day, while this technique is expected to allow researchers the ability to screen more than a billion possible drug candidates in that time.
Wake Forest is conducting the project in partnership with the University of Waterloo in Ontario, Canada, with funding from the North Carolina Biotechnology Center.
- read The Business Journal for more
Related Articles:
Cancer drug reverses damage from genetic disorder
Screening method IDs host of HIV drug targets
Biovest wants accelerated approval for anti-cancer vax
Cancer groups compete for research funds
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
